Pulmonx Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pulmonx Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7222
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfully predict outcomes and provide optimal treatment for each individual patient. The company provides Chartis System which is a proprietary pulmonary assessment tool that allows physicians to identify the patients with low or no collateral ventilation. Pulmonx provides Zephyr device which is one-way valve that helps to reduce hyperinflation of the lungs caused by emphysema and improves lung function. The company also provides AeriSeal System which uses polymeric foam to block diseased regions in the lung for volume reduction and improve breathing function. Pulmonx headquartered in Redwood, California, the US.

Pulmonx Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pulmonx Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pulmonx Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pulmonx Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pulmonx Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pulmonx Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pulmonx Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Pulmonx Acquires Assets from Aeris Therapeutics 10
Venture Financing 11
Pulmonx Raises US$10 Million In Venture Financing 11
Pulmonx Raises US$10 Million In Series D Financing 12
Pulmonx Corp – Key Competitors 13
Pulmonx Corp – Key Employees 14
Pulmonx Corp – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Pulmonx Corp, Medical Equipment, Key Facts 2
Pulmonx Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pulmonx Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pulmonx Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pulmonx Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pulmonx Corp, Deals By Market, 2012 to YTD 2018 8
Pulmonx Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pulmonx Acquires Assets from Aeris Therapeutics 10
Pulmonx Raises US$10 Million In Venture Financing 11
Pulmonx Raises US$10 Million In Series D Financing 12
Pulmonx Corp, Key Competitors 13
Pulmonx Corp, Key Employees 14

List of Figures
Pulmonx Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pulmonx Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pulmonx Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pulmonx Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pulmonx Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pulmonx Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pulmonx Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pulmonx Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pulmonx Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • Pakistan International Airlines Corporation
    Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report Summary Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Barnwell Industries Inc (BRN):石油・ガス:M&Aディール及び事業提携情報
    Summary Barnwell Industries Inc (Barnwell) is a diversified company. The company's business activities include oil and natural gas, land investment, and contract drilling. Its oil and natural gas division offers exploration, development, production, and sales of oil and natural gas in Canada. Barnwe …
  • EBSCO Industries Inc.:企業の戦略・SWOT・財務分析
    EBSCO Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary EBSCO Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Adana Cimento Sanayii Tas:企業の戦略・SWOT・財務分析
    Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report Summary Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Secure Trust Bank Plc:企業の戦略・SWOT・財務情報
    Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • VeriFone Systems Inc:企業のM&A・事業提携・投資動向
    VeriFone Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VeriFone Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Trafigura Group Pte. Ltd.-石油・ガス分野:企業M&A・提携分析
    Summary Trafigura Group Pte. Ltd. (Trafigura), a subsidiary of Trafigura Beheer B.V., is an independent commodity trading and logistics company. Its operations include trading of physical commodities, shipping and chartering, and asset management. The company sources, stores, transports and delivers …
  • Piper Jaffray Companies:企業の戦略・SWOT・財務情報
    Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report Summary Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • National Heart Lung and Blood Institute-製薬・医療分野:企業M&A・提携分析
    Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs …
  • Doosan Heavy Industries & Construction Co Ltd (034020):電力:M&Aディール及び事業提携情報
    Summary Doosan Heavy Industries & Construction Co Ltd (Doosan Heavy Industries), a subsidiary of Doosan Corporation, is a power plant equipment manufacturer. It offers integrated equipment and solutions for power and water plants. The company’s major products include boilers, generators, engines, tu …
  • Fronius International GmbH:企業の戦略的SWOT分析
    Fronius International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Longyuan Power Group Corporation Ltd (916):企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corporation Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • ON Semiconductor Corp (ON):企業の財務・戦略的SWOT分析
    ON Semiconductor Corp (ON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Imperial Brands Plc:企業のM&A・事業提携・投資動向
    Imperial Brands Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imperial Brands Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Paladin Energy Ltd (PDN):企業の財務・戦略的SWOT分析
    Paladin Energy Ltd (PDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sierra Oncology Inc (SRRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • Mastech Digital Inc (MHH):企業の財務・戦略的SWOT分析
    Summary Mastech Digital Inc (Mastech) operates as an IT staffing company that offers digital transformation services. The company offers services such as database administration, middleware, business analytics and QA, data warehousing, admin desktop fiac, and project management services, among other …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆